parthenolide has been researched along with Abdominal Migraine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greco, R; Morazzoni, P; Nappi, G; Riva, A; Sandrini, G; Tassorelli, C | 1 |
Carty, HC | 1 |
Bolay, H; Chiarugi, A; Moskowitz, MA; Reuter, U | 1 |
3 other study(ies) available for parthenolide and Abdominal Migraine
Article | Year |
---|---|
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Immunohistochemistry; Male; Migraine Disorders; Neurons; NF-kappa B; Nitroglycerin; Oncogene Proteins v-fos; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tanacetum parthenium; Vasodilator Agents | 2005 |
Herbal preparations under scientific scrutiny.
Topics: Canada; Drug Approval; Humans; Migraine Disorders; Phytotherapy; Sesquiterpenes | 1996 |
Nuclear factor-kappaB as a molecular target for migraine therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA-Binding Proteins; Dura Mater; I-kappa B Proteins; Macrophages; Male; Migraine Disorders; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sesquiterpenes; Vasodilator Agents | 2002 |